tradingkey.logo

Merck rises as drugmaker revamps human health business

ReutersFeb 23, 2026 11:57 AM

Shares of drugmaker Merck MRK.N rise 1.5% to $124.10 premarket

 Co says it will split its human health operations into an Oncology unit and a Specialty, Pharma & Infectious Diseases unit to improve performance ahead of multiple product launches

  Co says Jannie Oosthuizen will lead oncology; Brian Foard joins from Sanofi SASY.PA to head the second unit starting March 2

Says restructuring supports its late‑stage pipeline, which includes about 80 late‑stage studies and more than 20 potential new products

  Co also names Chirfi Guindo as executive vice president for Strategic Access, Policy & Communication

Merck shares rose ~6% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI